education · health · HHS-NIH11
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
National Institutes of Health · PAR-25-324
Deadline
September 7, 2028
GRANTQUICK SUMMARYPlain-English Overview
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional). National Institutes of Health. The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and... Funding amounts not specified.
Who Should Apply
Public universities/colleges, Private universities/colleges, Federally Recognized Native American Tribal Governments, Nonprofits (501c3), Small businesses (+10 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Is...
- •Deadline: 2028-09-07
💡 GrantQuick Tip
Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.
Competitiveness: Moderate to high — federal grants are always competitive
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
NIH Grants Information grantsinfo@nih.gov
grantsinfo@nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov